Kymera Therapeutics, Inc. · NASDAQ:KYMR
T. Rowe Price Associates Inc reported a 10.70% stake in Kymera Therapeutics, Inc. (Schedule 13G/A)
Event Aug 31, 2026 · Filed Sep 8, 2026
T. Rowe Price Associates Inc reported a 10.70% stake in Kymera Therapeutics, Inc., 8,873,588 shares, as a passive investor on Aug 31, 2026. Filed Sep 8, 2026 (Schedule 13G/A).
- Stake
- 10.70%
- Shares
- 8,873,588
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| T. Rowe Price Associates, Inc. | 10.70% | 8,873,588 |
Source
Related
- Kymera Therapeutics, Inc.
- T. Rowe Price Associates Inc
- Kymera Therapeutics, Inc. shareholders
- Schedule 13G/A · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Nov 14, 2025
- Form 4 · Mainolfi Nello · Oct 1, 2026
- Form 4 · Adams Brian · Sep 4, 2026
- Schedule 13G/A · Atlas Venture Fund X, L.P. · Aug 13, 2026
- Form 4 · Rooney Terence · Jul 27, 2026
- Form 4 · Mainolfi Nello · Jul 7, 2026